Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Digestive System Diseases

Rare Diseases

Carcinoma, Renal Cell

Liver Neoplasms

Kidney Neoplasms

Urologic Neoplasms

Urogenital Neoplasms

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Kidney Diseases

Urologic Diseases

Male Urogenital Diseases

Renal Cell Carcinoma

Hematinics

All Drugs and Chemicals

Liver Extracts

Patients with liver cancer, renal cancer, rectal cancer will be treated by telesurgery.

Patients with liver cancer, renal cancer, rectal cancer will be treated by laparoscopic surgery.

Robotic telesurgery

Laparoscopic surgery

Kuang Ming, PhD

This is a randomized controlled trial that will be preceded by a safety trial focusing on the safety and efficacy of robotic telesurgery. The hypothesis is that robotic telesurgery has a non-inferior primary endpoint event rate to local laparoscopic surgery.

First, a safety run-in trial for robotic telesurgery will be conducted and evaluated according to "3+3 design". At least 3 patients of each cancer type (including liver cancer,renal cancer and rectal cancer) will be enrolled for robotic telesurgery. If there is a tumor type for which the prior safety trial is terminated, the subsequent randomized controlled trial will not include patients of that type.

Second, after passing the safety run-in trial, a randomized controlled trial will be performed. New patients with each cancer type who met the enrollment criteria will be randomly assigned to either the laparoscopic surgery group(control group) or the robotic telesurgery group (intervention group) (84 patients in each group, 168 patients in total) in a 1:1 two-group parallel design.

A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery

Overall complication events within 30 days of surgery or intraoperative emergency intermediate open surgery events as defined by the Clavin-Dindo grading system

Total time from the start of surgery after robotic or laparoscopic installation to the end of incision closure and the surgeon's operating time.

Total bleeding from the start of surgery to the end of incision suturing.

Number of days from the day of surgery to the day of discharge.

A NASA-TLX quantification form was completed by the physician postoperatively.

Record data related to network transmission end-to-end latency time, jitter, and frame loss.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery	NCT06369597	Liver Cancer Renal Cancer Rectal Cancer	Robotic telesur... Laparoscopic su...	18 Years - 75 Years	Sun Yat-sen University
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery	NCT06369597	Liver Cancer Renal Cancer Rectal Cancer	Robotic telesur... Laparoscopic su...	18 Years - 75 Years	Sun Yat-sen University

Spots Global Cancer Trial Database for robotic telesurgery